Microencapsulated antibodies in radioimmunoassay--I. Determination of digoxin.
We describe the application of the microencapsulated-antibody technique to the radioimmunoassay of digoxin in serum. Droplets of emulsified rabbit antibody are microencapsulated in a semipermeable nylon membrane by an interfacial polymerization technique. The antibody microcapsules are incubated with 125I-labeled digoxin and unlabeled digoxin for 15 min at 37 degrees C, then free and bound digoxin are separated by centrifugation. Subtherapeutic, therapeutic, and toxic concentrations of digoxin in sera can be determined, with use of a standard curve prepared by use of known amounts of digoxin. With this technique we obtained an intra-laboratory correlation coefficient of 0.945 for 100 patients' sera and one of 0.940 for interlaboratory results for 21 sera (10 laboratories) when compared to a routine clinical laboratory radioimmunoassay for digoxin. Icterus, lipemia, hemoglobin, or disproteinemia had no effect on the analytical recovery of digoxin. The standard curve was linear to 6 microgram/L; the sensitivity was 0.25 microgram/L.
D000906:Antibodies; D001663:Bilirubin / Q000097:blood; D004077:Digoxin / Q000097:blood*; D006461:Hemolysis; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood; D008567:Membranes, Artificial; D011863:Radioimmunoassay / Q000379:methods*; D014280:Triglycerides / Q000097:blood; D005719:gamma-Globulins
D000906:Antibodies; D008567:Membranes, Artificial; D014280:Triglycerides; D005719:gamma-Globulins; D004077:Digoxin; D001663:Bilirubin